Dr. Louis H. Heitke, DDS in Madison, Wisconsin
-
Best Treatments for Lupus in 2025: What Doctors Recommend
This article distills what rheumatologists recommend in 2025 for managing lupus, from time‑tested essentials like hydroxychloroquine and short courses of low‑dose steroids to steroid‑sparing immunosuppressants (mycophenolate, azathioprine, methotrexate), newer biologics (belimumab, anifrolumab), and kidney‑targeted options for lupus nephritis (mycophenolate, voclosporin). It explains how doctors use a treat‑to‑target approach—aiming for low disease activity, minimizing steroid exposure, and monitoring labs—to personalize therapy based on symptoms, organ involvement, pregnancy plans, and patient priorities. Readers will also find practical tips on sun protection, vaccinations, heart and bone health, mental well‑being, and building a care team, empowering patients and caregivers to have informed, confident conversations with their clinicians.
-
Medicare weight-loss drugs in 2026: how the new $50 bridge works
CMS says a temporary nationwide Medicare bridge for certain obesity medicines starts July 1, 2026. Here is who may qualify, which drugs are included, what the $50 copay does and does not cover, and when ordinary Part D rules still apply.
-
Aurora Sheboygan Prices – BX SKIN TAGENTIAL EA ADD LESION is $220
At Aurora Medical Center Sheboygan, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10006294, regarding BX SKIN TAGENTIAL EA ADD LESION, which is classified under revenue code 360 and associated with CPT code 11103, the designated fee stands at $220. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Could the updated COVID-19 vaccine also lower heart attack and stroke risk?
A large U.S. study of veterans found the 2024-2025 COVID vaccine was associated with fewer COVID-linked major cardiovascular events, including heart attack, stroke, heart-failure hospitalization, and cardiovascular death. The benefit looked strongest in older adults and people with chronic conditions, but the study cannot prove cause and effect.